| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis, Acute Necrotizing | 12 | 2023 | 172 | 6.020 |
Why?
|
| Debridement | 9 | 2023 | 491 | 3.020 |
Why?
|
| Cholecystectomy, Laparoscopic | 7 | 2021 | 224 | 2.360 |
Why?
|
| Drainage | 8 | 2023 | 1139 | 2.190 |
Why?
|
| Altitude Sickness | 8 | 2011 | 91 | 1.970 |
Why?
|
| Altitude | 7 | 2011 | 160 | 1.590 |
Why?
|
| Pancreatitis | 6 | 2022 | 1082 | 1.510 |
Why?
|
| Cholecystitis, Acute | 4 | 2018 | 70 | 1.360 |
Why?
|
| Pulmonary Edema | 5 | 2011 | 415 | 1.270 |
Why?
|
| Embolization, Therapeutic | 3 | 2022 | 1376 | 0.930 |
Why?
|
| Endoscopy | 5 | 2023 | 1762 | 0.920 |
Why?
|
| Choledocholithiasis | 2 | 2021 | 48 | 0.910 |
Why?
|
| Gallstones | 3 | 2020 | 286 | 0.900 |
Why?
|
| Duodenal Ulcer | 1 | 2022 | 125 | 0.870 |
Why?
|
| Intestinal Fistula | 5 | 2021 | 140 | 0.860 |
Why?
|
| Malnutrition | 5 | 2020 | 613 | 0.830 |
Why?
|
| Intraoperative Complications | 9 | 2020 | 1184 | 0.790 |
Why?
|
| Mountaineering | 4 | 2010 | 45 | 0.750 |
Why?
|
| Cutaneous Fistula | 4 | 2021 | 78 | 0.750 |
Why?
|
| Length of Stay | 18 | 2022 | 6294 | 0.750 |
Why?
|
| Nutrition Therapy | 2 | 2019 | 96 | 0.750 |
Why?
|
| Enterocolitis, Pseudomembranous | 3 | 2017 | 264 | 0.720 |
Why?
|
| Intensive Care Units | 15 | 2022 | 3672 | 0.700 |
Why?
|
| Enteral Nutrition | 9 | 2022 | 758 | 0.700 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2021 | 504 | 0.690 |
Why?
|
| Gallbladder | 3 | 2020 | 300 | 0.660 |
Why?
|
| Appendicitis | 4 | 2021 | 639 | 0.650 |
Why?
|
| Hemorrhage | 6 | 2021 | 3440 | 0.630 |
Why?
|
| Pancreas | 5 | 2020 | 1677 | 0.630 |
Why?
|
| Cholecystostomy | 1 | 2017 | 46 | 0.590 |
Why?
|
| Surgical Wound Infection | 6 | 2022 | 1530 | 0.590 |
Why?
|
| Intracranial Hypertension | 2 | 2011 | 185 | 0.580 |
Why?
|
| Cholecystectomy | 3 | 2017 | 387 | 0.580 |
Why?
|
| Abdominal Abscess | 2 | 2015 | 153 | 0.580 |
Why?
|
| Critical Illness | 14 | 2022 | 2656 | 0.580 |
Why?
|
| Cholecystitis | 4 | 2020 | 182 | 0.560 |
Why?
|
| Surgical Procedures, Operative | 8 | 2020 | 1867 | 0.550 |
Why?
|
| Fasciitis, Necrotizing | 3 | 2021 | 79 | 0.540 |
Why?
|
| Wounds and Injuries | 8 | 2023 | 2395 | 0.530 |
Why?
|
| Intracranial Pressure | 2 | 2008 | 327 | 0.530 |
Why?
|
| Erythrocyte Transfusion | 4 | 2023 | 565 | 0.520 |
Why?
|
| Cholelithiasis | 1 | 2017 | 410 | 0.520 |
Why?
|
| Pancreatic Fistula | 1 | 2016 | 144 | 0.520 |
Why?
|
| Postoperative Complications | 14 | 2021 | 15191 | 0.500 |
Why?
|
| Optic Nerve | 2 | 2008 | 558 | 0.490 |
Why?
|
| Digestive System Surgical Procedures | 5 | 2021 | 568 | 0.490 |
Why?
|
| Trauma Centers | 10 | 2023 | 888 | 0.490 |
Why?
|
| Bile Duct Diseases | 1 | 2014 | 99 | 0.480 |
Why?
|
| Hospital Mortality | 11 | 2021 | 5305 | 0.480 |
Why?
|
| Soft Tissue Infections | 3 | 2021 | 156 | 0.470 |
Why?
|
| Myelin Sheath | 2 | 2008 | 664 | 0.470 |
Why?
|
| Ultrasonography | 5 | 2015 | 5941 | 0.460 |
Why?
|
| Abdominal Injuries | 4 | 2022 | 351 | 0.460 |
Why?
|
| Radiography, Abdominal | 2 | 2020 | 535 | 0.450 |
Why?
|
| Glasgow Outcome Scale | 1 | 2013 | 109 | 0.450 |
Why?
|
| Retrospective Studies | 49 | 2023 | 76632 | 0.440 |
Why?
|
| Male | 99 | 2022 | 348967 | 0.420 |
Why?
|
| Middle Aged | 76 | 2021 | 212833 | 0.410 |
Why?
|
| Meckel Diverticulum | 1 | 2011 | 34 | 0.410 |
Why?
|
| Teichoic Acids | 1 | 2012 | 66 | 0.410 |
Why?
|
| Abdomen | 4 | 2019 | 1102 | 0.400 |
Why?
|
| Bezoars | 1 | 2011 | 30 | 0.400 |
Why?
|
| Emergencies | 7 | 2022 | 1152 | 0.400 |
Why?
|
| Humans | 123 | 2023 | 739219 | 0.380 |
Why?
|
| Natural Orifice Endoscopic Surgery | 1 | 2012 | 118 | 0.380 |
Why?
|
| Abdominal Wound Closure Techniques | 2 | 2022 | 33 | 0.380 |
Why?
|
| Abdominal Wall | 2 | 2022 | 155 | 0.370 |
Why?
|
| Critical Care | 8 | 2021 | 2624 | 0.360 |
Why?
|
| Pneumonia | 1 | 2022 | 2102 | 0.360 |
Why?
|
| Polyurethanes | 3 | 2015 | 107 | 0.360 |
Why?
|
| Inflammation | 6 | 2018 | 10531 | 0.350 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2015 | 789 | 0.350 |
Why?
|
| Female | 91 | 2022 | 378808 | 0.350 |
Why?
|
| Alkaline Phosphatase | 6 | 2021 | 864 | 0.350 |
Why?
|
| Aged | 55 | 2022 | 162667 | 0.340 |
Why?
|
| Restraint, Physical | 1 | 2010 | 193 | 0.330 |
Why?
|
| Adult | 58 | 2023 | 213375 | 0.330 |
Why?
|
| Nutritional Status | 6 | 2020 | 1587 | 0.330 |
Why?
|
| Laparotomy | 4 | 2022 | 472 | 0.330 |
Why?
|
| Bupivacaine | 1 | 2012 | 409 | 0.330 |
Why?
|
| Retroperitoneal Space | 2 | 2019 | 171 | 0.320 |
Why?
|
| Tomography, X-Ray Computed | 14 | 2020 | 20038 | 0.320 |
Why?
|
| Emergency Service, Hospital | 7 | 2022 | 7626 | 0.320 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2016 | 1005 | 0.310 |
Why?
|
| Intestinal Obstruction | 1 | 2011 | 425 | 0.310 |
Why?
|
| Emergency Medical Services | 4 | 2021 | 1904 | 0.310 |
Why?
|
| Injury Severity Score | 9 | 2022 | 1011 | 0.300 |
Why?
|
| Referral and Consultation | 2 | 2017 | 3514 | 0.290 |
Why?
|
| Blood Proteins | 1 | 2012 | 1122 | 0.290 |
Why?
|
| Pain, Postoperative | 2 | 2018 | 1638 | 0.290 |
Why?
|
| Nepal | 4 | 2008 | 289 | 0.280 |
Why?
|
| Patient Transfer | 1 | 2013 | 763 | 0.280 |
Why?
|
| Hypophosphatemia | 2 | 2017 | 85 | 0.280 |
Why?
|
| General Surgery | 4 | 2018 | 1630 | 0.270 |
Why?
|
| Treatment Outcome | 23 | 2023 | 62691 | 0.270 |
Why?
|
| Duodenum | 2 | 2022 | 481 | 0.270 |
Why?
|
| Laparoscopy | 2 | 2022 | 2089 | 0.270 |
Why?
|
| Nerve Block | 1 | 2012 | 638 | 0.270 |
Why?
|
| Hospitalization | 10 | 2020 | 10208 | 0.260 |
Why?
|
| Intestine, Small | 1 | 2011 | 1242 | 0.260 |
Why?
|
| Heart Rate | 5 | 2015 | 4095 | 0.260 |
Why?
|
| Anesthetics, Local | 1 | 2012 | 985 | 0.260 |
Why?
|
| Neck Injuries | 2 | 2018 | 152 | 0.260 |
Why?
|
| Exsanguination | 2 | 2015 | 27 | 0.260 |
Why?
|
| Emergency Treatment | 2 | 2018 | 516 | 0.250 |
Why?
|
| Acute Disease | 5 | 2022 | 7127 | 0.250 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2208 | 0.240 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2007 | 363 | 0.240 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2007 | 475 | 0.240 |
Why?
|
| Hemostatic Techniques | 2 | 2014 | 116 | 0.230 |
Why?
|
| Thoracic Injuries | 3 | 2021 | 270 | 0.230 |
Why?
|
| Risk Factors | 27 | 2022 | 71972 | 0.220 |
Why?
|
| Hernia, Ventral | 2 | 2022 | 154 | 0.220 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2022 | 49 | 0.220 |
Why?
|
| Necrosis | 3 | 2023 | 1641 | 0.220 |
Why?
|
| Patient Admission | 2 | 2020 | 1383 | 0.220 |
Why?
|
| Thromboembolism | 2 | 2021 | 984 | 0.210 |
Why?
|
| Blood Transfusion | 4 | 2023 | 1296 | 0.210 |
Why?
|
| Severity of Illness Index | 8 | 2015 | 15510 | 0.210 |
Why?
|
| Wounds, Gunshot | 2 | 2021 | 562 | 0.210 |
Why?
|
| Hemoperitoneum | 1 | 2022 | 40 | 0.210 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 976 | 0.210 |
Why?
|
| Aged, 80 and over | 20 | 2021 | 57639 | 0.210 |
Why?
|
| Triage | 3 | 2021 | 975 | 0.210 |
Why?
|
| Risk Assessment | 12 | 2021 | 23292 | 0.210 |
Why?
|
| Fournier Gangrene | 1 | 2021 | 21 | 0.210 |
Why?
|
| Hepatic Artery | 1 | 2022 | 242 | 0.200 |
Why?
|
| Brain Injuries | 1 | 2013 | 2021 | 0.200 |
Why?
|
| Hospital Costs | 1 | 2007 | 982 | 0.190 |
Why?
|
| Indiana | 1 | 2020 | 92 | 0.190 |
Why?
|
| Portal System | 1 | 2020 | 52 | 0.190 |
Why?
|
| Panniculitis | 1 | 2020 | 42 | 0.190 |
Why?
|
| Cervical Vertebrae | 2 | 2018 | 972 | 0.190 |
Why?
|
| Prospective Studies | 19 | 2021 | 53036 | 0.190 |
Why?
|
| Plasma | 2 | 2023 | 573 | 0.180 |
Why?
|
| Aspartate Aminotransferases | 1 | 2021 | 418 | 0.170 |
Why?
|
| Rib Fractures | 1 | 2020 | 130 | 0.170 |
Why?
|
| Bilirubin | 1 | 2021 | 415 | 0.170 |
Why?
|
| Rectus Abdominis | 1 | 2019 | 94 | 0.170 |
Why?
|
| Crowding | 1 | 2020 | 145 | 0.170 |
Why?
|
| Nutrition Assessment | 2 | 2019 | 717 | 0.170 |
Why?
|
| Dietary Proteins | 4 | 2018 | 959 | 0.160 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 118 | 0.160 |
Why?
|
| Time Factors | 10 | 2020 | 40040 | 0.160 |
Why?
|
| Ileostomy | 1 | 2019 | 119 | 0.160 |
Why?
|
| Video-Assisted Surgery | 1 | 2018 | 51 | 0.160 |
Why?
|
| Cholangiography | 1 | 2018 | 189 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 5 | 2002 | 1997 | 0.160 |
Why?
|
| Diagnostic Techniques, Digestive System | 1 | 2018 | 47 | 0.160 |
Why?
|
| Training Support | 1 | 2018 | 113 | 0.160 |
Why?
|
| Protein-Energy Malnutrition | 2 | 2018 | 187 | 0.160 |
Why?
|
| Protein Deficiency | 1 | 2017 | 61 | 0.160 |
Why?
|
| Sepsis | 1 | 2012 | 2571 | 0.160 |
Why?
|
| Acetazolamide | 2 | 2008 | 100 | 0.150 |
Why?
|
| Duodenoscopy | 1 | 2017 | 52 | 0.150 |
Why?
|
| Diverticulitis, Colonic | 1 | 2019 | 126 | 0.150 |
Why?
|
| Hospitals, Community | 1 | 2020 | 347 | 0.150 |
Why?
|
| Psoas Muscles | 1 | 2018 | 71 | 0.150 |
Why?
|
| Wounds, Penetrating | 1 | 2019 | 306 | 0.150 |
Why?
|
| United States | 20 | 2021 | 69568 | 0.150 |
Why?
|
| Refeeding Syndrome | 1 | 2016 | 14 | 0.150 |
Why?
|
| Bile | 1 | 2018 | 295 | 0.150 |
Why?
|
| Osteoblasts | 3 | 2001 | 1163 | 0.140 |
Why?
|
| Predictive Value of Tests | 8 | 2021 | 15035 | 0.140 |
Why?
|
| Sensitivity and Specificity | 7 | 2018 | 14721 | 0.140 |
Why?
|
| After-Hours Care | 1 | 2017 | 102 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 531 | 0.140 |
Why?
|
| Prealbumin | 1 | 2018 | 209 | 0.140 |
Why?
|
| Survival Rate | 6 | 2021 | 12760 | 0.140 |
Why?
|
| Appendectomy | 2 | 2018 | 398 | 0.140 |
Why?
|
| Acrylic Resins | 1 | 2016 | 142 | 0.140 |
Why?
|
| Digestive System Fistula | 1 | 2015 | 8 | 0.140 |
Why?
|
| Catheters | 1 | 2019 | 419 | 0.140 |
Why?
|
| Dura Mater | 4 | 2002 | 288 | 0.140 |
Why?
|
| Burns | 1 | 2007 | 1808 | 0.140 |
Why?
|
| Protein Isoforms | 1 | 2001 | 1725 | 0.140 |
Why?
|
| Biomedical Research | 1 | 2011 | 3300 | 0.140 |
Why?
|
| Quality Improvement | 5 | 2019 | 3730 | 0.130 |
Why?
|
| Anxiety Disorders | 1 | 2007 | 2674 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 2 | 2021 | 1162 | 0.130 |
Why?
|
| Massachusetts | 4 | 2021 | 8668 | 0.130 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2022 | 1127 | 0.130 |
Why?
|
| Arthritis | 1 | 2020 | 657 | 0.130 |
Why?
|
| Delayed Diagnosis | 2 | 2015 | 429 | 0.130 |
Why?
|
| Serum Albumin | 1 | 2018 | 669 | 0.130 |
Why?
|
| Wounds, Stab | 1 | 2015 | 71 | 0.130 |
Why?
|
| Shock, Septic | 1 | 2021 | 764 | 0.130 |
Why?
|
| Gelatin | 1 | 2016 | 225 | 0.130 |
Why?
|
| Geriatric Assessment | 2 | 2020 | 1366 | 0.130 |
Why?
|
| Efficiency, Organizational | 1 | 2019 | 694 | 0.130 |
Why?
|
| Leukocyte Count | 1 | 2018 | 1583 | 0.120 |
Why?
|
| Viscoelastic Substances | 1 | 2014 | 19 | 0.120 |
Why?
|
| Logistic Models | 8 | 2016 | 13400 | 0.120 |
Why?
|
| Glasgow Coma Scale | 4 | 2020 | 568 | 0.120 |
Why?
|
| Pneumothorax | 2 | 2020 | 379 | 0.120 |
Why?
|
| Databases, Factual | 9 | 2020 | 7689 | 0.120 |
Why?
|
| Truth Disclosure | 1 | 2018 | 437 | 0.120 |
Why?
|
| Fees and Charges | 1 | 2015 | 195 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2018 | 788 | 0.120 |
Why?
|
| Energy Intake | 3 | 2018 | 2135 | 0.120 |
Why?
|
| Comorbidity | 7 | 2022 | 10362 | 0.120 |
Why?
|
| Arteriovenous Malformations | 1 | 2016 | 396 | 0.110 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 70 | 0.110 |
Why?
|
| Hematoma, Epidural, Cranial | 1 | 2013 | 59 | 0.110 |
Why?
|
| Reflex, Pupillary | 1 | 2013 | 61 | 0.110 |
Why?
|
| Radar | 1 | 2012 | 10 | 0.110 |
Why?
|
| Cohort Studies | 6 | 2022 | 40385 | 0.110 |
Why?
|
| Cholangitis | 1 | 2014 | 108 | 0.110 |
Why?
|
| Colon | 1 | 2021 | 1770 | 0.110 |
Why?
|
| Calcifediol | 1 | 2014 | 166 | 0.110 |
Why?
|
| Oxygen Consumption | 2 | 2010 | 1869 | 0.110 |
Why?
|
| Hemostatics | 1 | 2015 | 227 | 0.110 |
Why?
|
| Ischemia | 1 | 2021 | 1908 | 0.110 |
Why?
|
| Mycetoma | 1 | 2012 | 12 | 0.110 |
Why?
|
| Preoperative Care | 2 | 2019 | 2237 | 0.110 |
Why?
|
| Gangrene | 2 | 2015 | 82 | 0.110 |
Why?
|
| Parenteral Nutrition | 1 | 2017 | 649 | 0.110 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3143 | 0.110 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3248 | 0.100 |
Why?
|
| Spinal Injuries | 1 | 2015 | 301 | 0.100 |
Why?
|
| Diagnosis, Differential | 5 | 2020 | 12945 | 0.100 |
Why?
|
| Benchmarking | 2 | 2017 | 1035 | 0.100 |
Why?
|
| Fluoroscopy | 1 | 2016 | 915 | 0.100 |
Why?
|
| Violence | 1 | 2018 | 907 | 0.100 |
Why?
|
| Warfarin | 1 | 2020 | 1484 | 0.100 |
Why?
|
| Peritonitis | 1 | 2014 | 365 | 0.100 |
Why?
|
| Diverticulitis | 1 | 2014 | 169 | 0.100 |
Why?
|
| Spinal Fractures | 1 | 2018 | 697 | 0.100 |
Why?
|
| Perioperative Care | 1 | 2019 | 995 | 0.100 |
Why?
|
| Lung Diseases, Fungal | 1 | 2012 | 122 | 0.100 |
Why?
|
| Acute Kidney Injury | 2 | 2021 | 1941 | 0.100 |
Why?
|
| Age Factors | 5 | 2021 | 18347 | 0.100 |
Why?
|
| Blood Platelets | 1 | 2022 | 2505 | 0.100 |
Why?
|
| Anticoagulants | 3 | 2022 | 4582 | 0.100 |
Why?
|
| Risk Adjustment | 1 | 2015 | 591 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2017 | 1477 | 0.100 |
Why?
|
| Incidence | 9 | 2020 | 20912 | 0.100 |
Why?
|
| Iatrogenic Disease | 1 | 2014 | 544 | 0.090 |
Why?
|
| Fractures, Bone | 1 | 2022 | 1939 | 0.090 |
Why?
|
| Cranial Sutures | 2 | 2001 | 92 | 0.090 |
Why?
|
| Patient Discharge | 3 | 2021 | 3286 | 0.090 |
Why?
|
| Thoracotomy | 1 | 2012 | 365 | 0.090 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2014 | 501 | 0.090 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 932 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2022 | 1673 | 0.090 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 477 | 0.090 |
Why?
|
| Ethanol | 1 | 2016 | 1329 | 0.090 |
Why?
|
| Fascia | 2 | 2022 | 134 | 0.090 |
Why?
|
| Blast Injuries | 1 | 2013 | 298 | 0.090 |
Why?
|
| Communicable Diseases | 1 | 2018 | 874 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2022 | 2365 | 0.090 |
Why?
|
| Patient Rights | 1 | 2010 | 125 | 0.090 |
Why?
|
| Entropy | 3 | 2015 | 209 | 0.090 |
Why?
|
| Young Adult | 10 | 2021 | 56252 | 0.090 |
Why?
|
| Abbreviated Injury Scale | 2 | 2022 | 51 | 0.090 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 1175 | 0.090 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 606 | 0.090 |
Why?
|
| Drug Administration Schedule | 2 | 2020 | 4935 | 0.090 |
Why?
|
| Respiration, Artificial | 2 | 2017 | 2560 | 0.090 |
Why?
|
| Follow-Up Studies | 7 | 2020 | 38941 | 0.090 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2017 | 1557 | 0.090 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 2749 | 0.080 |
Why?
|
| Mortality | 1 | 2020 | 2851 | 0.080 |
Why?
|
| Brain Concussion | 1 | 2020 | 1316 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2018 | 1637 | 0.080 |
Why?
|
| Shock | 2 | 2021 | 318 | 0.080 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2008 | 95 | 0.080 |
Why?
|
| Multivariate Analysis | 6 | 2020 | 12235 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 1957 | 0.080 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2120 | 0.080 |
Why?
|
| Radiography, Interventional | 1 | 2015 | 1093 | 0.080 |
Why?
|
| Thoracic Vertebrae | 1 | 2012 | 607 | 0.080 |
Why?
|
| Operating Rooms | 3 | 2019 | 804 | 0.070 |
Why?
|
| Ultrasonography, Interventional | 1 | 2015 | 1480 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1850 | 0.070 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2007 | 88 | 0.070 |
Why?
|
| Pandemics | 3 | 2022 | 8274 | 0.070 |
Why?
|
| Anesthesia, General | 1 | 2014 | 1164 | 0.070 |
Why?
|
| Burn Units | 1 | 2007 | 136 | 0.070 |
Why?
|
| Skin | 1 | 2020 | 4324 | 0.070 |
Why?
|
| Clostridium Infections | 1 | 2014 | 549 | 0.070 |
Why?
|
| Bed Rest | 1 | 2007 | 84 | 0.070 |
Why?
|
| Internship and Residency | 2 | 2018 | 5761 | 0.070 |
Why?
|
| Hospitals | 2 | 2017 | 3916 | 0.070 |
Why?
|
| Nifedipine | 1 | 2007 | 227 | 0.070 |
Why?
|
| Adolescent | 8 | 2020 | 85409 | 0.070 |
Why?
|
| Skull | 2 | 2001 | 809 | 0.070 |
Why?
|
| Patient Selection | 1 | 2018 | 4211 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 7274 | 0.070 |
Why?
|
| Albuterol | 1 | 2007 | 208 | 0.070 |
Why?
|
| Prognosis | 5 | 2015 | 28901 | 0.070 |
Why?
|
| Hospitals, Urban | 1 | 2007 | 503 | 0.070 |
Why?
|
| Collagen | 4 | 2001 | 2669 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2019 | 2867 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2007 | 363 | 0.060 |
Why?
|
| Recurrence | 1 | 2017 | 8306 | 0.060 |
Why?
|
| Intubation, Intratracheal | 1 | 2013 | 1349 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2017 | 5073 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2015 | 2261 | 0.060 |
Why?
|
| Stents | 1 | 2016 | 3257 | 0.060 |
Why?
|
| Sulfones | 1 | 2007 | 436 | 0.060 |
Why?
|
| Vitamin D Deficiency | 1 | 2014 | 1327 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2016 | 8553 | 0.060 |
Why?
|
| Hemodynamics | 2 | 2011 | 4196 | 0.060 |
Why?
|
| Osteocalcin | 2 | 2001 | 273 | 0.060 |
Why?
|
| Abdominal Pain | 2 | 2020 | 1053 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2001 | 12064 | 0.060 |
Why?
|
| Sialoglycoproteins | 2 | 2002 | 318 | 0.060 |
Why?
|
| Purines | 1 | 2007 | 593 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3036 | 0.060 |
Why?
|
| Mass Screening | 1 | 2019 | 5265 | 0.060 |
Why?
|
| Reference Values | 2 | 2010 | 4981 | 0.060 |
Why?
|
| Phosphates | 2 | 2017 | 785 | 0.060 |
Why?
|
| Extracellular Matrix | 2 | 2001 | 1734 | 0.060 |
Why?
|
| Child | 5 | 2015 | 77029 | 0.060 |
Why?
|
| Adaptation, Physiological | 1 | 2010 | 1310 | 0.060 |
Why?
|
| Morbidity | 2 | 2021 | 1763 | 0.050 |
Why?
|
| Hospitals, Teaching | 1 | 2007 | 1166 | 0.050 |
Why?
|
| Osteopontin | 2 | 2002 | 295 | 0.050 |
Why?
|
| Travel | 1 | 2008 | 787 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 2 | 2002 | 600 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2007 | 841 | 0.050 |
Why?
|
| Propensity Score | 2 | 2020 | 1748 | 0.050 |
Why?
|
| Curriculum | 1 | 2015 | 3575 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2018 | 3649 | 0.050 |
Why?
|
| Health Surveys | 2 | 2014 | 4022 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 15500 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3279 | 0.050 |
Why?
|
| Leg | 1 | 2007 | 1106 | 0.050 |
Why?
|
| Boston | 3 | 2021 | 9314 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2020 | 2881 | 0.050 |
Why?
|
| Blood Component Transfusion | 1 | 2022 | 142 | 0.050 |
Why?
|
| Radiology | 1 | 2015 | 2080 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2973 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1909 | 0.050 |
Why?
|
| Attitude of Health Personnel | 2 | 2015 | 3844 | 0.050 |
Why?
|
| Hypertension, Pulmonary | 1 | 2011 | 1525 | 0.050 |
Why?
|
| Prone Position | 1 | 2021 | 194 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2448 | 0.050 |
Why?
|
| Platelet Transfusion | 1 | 2023 | 314 | 0.050 |
Why?
|
| Neuromuscular Blockade | 1 | 2021 | 146 | 0.040 |
Why?
|
| Reoperation | 2 | 2020 | 4192 | 0.040 |
Why?
|
| Pressure Ulcer | 1 | 2021 | 154 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 17384 | 0.040 |
Why?
|
| Hypoalbuminemia | 1 | 2020 | 86 | 0.040 |
Why?
|
| Adenoviridae | 2 | 2001 | 1095 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 572 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 2021 | 694 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2020 | 519 | 0.040 |
Why?
|
| Atrial Fibrillation | 1 | 2017 | 5003 | 0.040 |
Why?
|
| Tokyo | 1 | 2018 | 25 | 0.040 |
Why?
|
| Linear Models | 1 | 2008 | 5946 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2020 | 681 | 0.040 |
Why?
|
| Gene Transfer Techniques | 2 | 2001 | 1227 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2021 | 316 | 0.040 |
Why?
|
| Hungary | 1 | 2017 | 84 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2007 | 2041 | 0.040 |
Why?
|
| Wound Healing | 2 | 2017 | 2771 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 407 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2018 | 527 | 0.040 |
Why?
|
| Osteogenesis | 2 | 2002 | 1292 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2017 | 6364 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2018 | 546 | 0.030 |
Why?
|
| Piperazines | 1 | 2007 | 2480 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2020 | 744 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 18002 | 0.030 |
Why?
|
| Rats | 6 | 2002 | 24259 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2015 | 40801 | 0.030 |
Why?
|
| Time | 1 | 2017 | 528 | 0.030 |
Why?
|
| Steroids | 1 | 2021 | 925 | 0.030 |
Why?
|
| Cytokines | 2 | 2001 | 7296 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 2021 | 994 | 0.030 |
Why?
|
| Neutrophils | 2 | 2018 | 3698 | 0.030 |
Why?
|
| Risk Management | 1 | 2019 | 571 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2019 | 983 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2001 | 2733 | 0.030 |
Why?
|
| Colectomy | 1 | 2020 | 681 | 0.030 |
Why?
|
| Germany | 1 | 2017 | 853 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2020 | 10939 | 0.030 |
Why?
|
| Blotting, Northern | 3 | 2002 | 1583 | 0.030 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2018 | 365 | 0.030 |
Why?
|
| Animals | 10 | 2014 | 168358 | 0.030 |
Why?
|
| Cells, Cultured | 5 | 2002 | 19223 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2001 | 879 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2020 | 2614 | 0.030 |
Why?
|
| APACHE | 1 | 2015 | 277 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10248 | 0.030 |
Why?
|
| Head | 1 | 2020 | 876 | 0.030 |
Why?
|
| Syndrome | 1 | 2020 | 3241 | 0.030 |
Why?
|
| Starvation | 1 | 2014 | 134 | 0.030 |
Why?
|
| Antimalarials | 1 | 2021 | 913 | 0.030 |
Why?
|
| Swine | 2 | 2014 | 5893 | 0.030 |
Why?
|
| Polymerization | 1 | 2014 | 163 | 0.030 |
Why?
|
| Vital Signs | 1 | 2015 | 141 | 0.030 |
Why?
|
| Tissue Adhesions | 1 | 2015 | 235 | 0.030 |
Why?
|
| Angiography | 1 | 2019 | 1634 | 0.030 |
Why?
|
| RNA, Messenger | 4 | 2001 | 13006 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 460 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3524 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 766 | 0.030 |
Why?
|
| Trauma Severity Indices | 1 | 2015 | 480 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 1264 | 0.030 |
Why?
|
| Netherlands | 1 | 2017 | 2169 | 0.030 |
Why?
|
| Organ Size | 1 | 2018 | 2248 | 0.030 |
Why?
|
| Permeability | 1 | 2014 | 737 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2022 | 2453 | 0.030 |
Why?
|
| Jejunum | 1 | 2014 | 480 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2020 | 1735 | 0.030 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2020 | 1018 | 0.030 |
Why?
|
| Canada | 1 | 2017 | 2021 | 0.030 |
Why?
|
| Ileum | 1 | 2014 | 563 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2001 | 2440 | 0.030 |
Why?
|
| Dietary Carbohydrates | 1 | 2017 | 904 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 24711 | 0.030 |
Why?
|
| Liver | 2 | 2020 | 7446 | 0.030 |
Why?
|
| Demography | 1 | 2016 | 1650 | 0.020 |
Why?
|
| Clinical Competence | 2 | 2018 | 4671 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2021 | 5050 | 0.020 |
Why?
|
| Electrocardiography | 2 | 2015 | 6425 | 0.020 |
Why?
|
| Multiple Trauma | 1 | 2014 | 366 | 0.020 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1571 | 0.020 |
Why?
|
| Cardiac Output | 1 | 2013 | 857 | 0.020 |
Why?
|
| India | 1 | 2017 | 2189 | 0.020 |
Why?
|
| Prevalence | 2 | 2020 | 15152 | 0.020 |
Why?
|
| Proliferating Cell Nuclear Antigen | 2 | 2002 | 283 | 0.020 |
Why?
|
| Nontherapeutic Human Experimentation | 1 | 2010 | 24 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2018 | 2615 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2000 | 3421 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 1339 | 0.020 |
Why?
|
| Environment, Controlled | 1 | 2010 | 46 | 0.020 |
Why?
|
| Health Services Research | 1 | 2018 | 1832 | 0.020 |
Why?
|
| Leukocytes | 1 | 2018 | 2036 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2002 | 8292 | 0.020 |
Why?
|
| Registries | 2 | 2015 | 8039 | 0.020 |
Why?
|
| Cell Division | 3 | 2002 | 4575 | 0.020 |
Why?
|
| Mice | 3 | 2014 | 80995 | 0.020 |
Why?
|
| Resuscitation | 1 | 2014 | 656 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3622 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2015 | 1145 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2019 | 1828 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2015 | 1008 | 0.020 |
Why?
|
| Dietary Fats | 1 | 2017 | 2013 | 0.020 |
Why?
|
| Clinical Protocols | 1 | 2015 | 1453 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2018 | 6451 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2014 | 2296 | 0.020 |
Why?
|
| Anesthetics | 1 | 2014 | 536 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2448 | 0.020 |
Why?
|
| Body Mass Index | 2 | 2017 | 12655 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2017 | 21691 | 0.020 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2010 | 381 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2018 | 19787 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2903 | 0.020 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2002 | 643 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3524 | 0.020 |
Why?
|
| Faculty, Medical | 1 | 2015 | 1179 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 677 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7716 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2001 | 11471 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 3909 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 11985 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2020 | 3106 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2018 | 3752 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 1146 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 4205 | 0.020 |
Why?
|
| Cross Infection | 1 | 2014 | 1414 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 4239 | 0.020 |
Why?
|
| Opioid-Related Disorders | 1 | 2018 | 2057 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12177 | 0.010 |
Why?
|
| Students, Medical | 1 | 2015 | 1850 | 0.010 |
Why?
|
| Transforming Growth Factor beta3 | 1 | 2002 | 44 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2018 | 4426 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2014 | 9846 | 0.010 |
Why?
|
| Pregnancy | 2 | 2019 | 29003 | 0.010 |
Why?
|
| Autocrine Communication | 1 | 2002 | 172 | 0.010 |
Why?
|
| DNA, Recombinant | 1 | 2001 | 475 | 0.010 |
Why?
|
| Paracrine Communication | 1 | 2002 | 276 | 0.010 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2001 | 185 | 0.010 |
Why?
|
| Vitamin D | 1 | 2014 | 3197 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 2000 | 723 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2002 | 577 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 813 | 0.010 |
Why?
|
| Gene Expression | 2 | 2002 | 7789 | 0.010 |
Why?
|
| Disease Progression | 1 | 2014 | 13237 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2000 | 1110 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7134 | 0.010 |
Why?
|
| Plasmids | 1 | 2001 | 2307 | 0.010 |
Why?
|
| Mandible | 1 | 2000 | 736 | 0.010 |
Why?
|
| Osteotomy | 1 | 2000 | 817 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2002 | 5180 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2000 | 4746 | 0.010 |
Why?
|
| Infant | 1 | 2014 | 34923 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 6609 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2000 | 6176 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 35274 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2000 | 11348 | 0.000 |
Why?
|
| Aging | 1 | 2000 | 8607 | 0.000 |
Why?
|